87 related articles for article (PubMed ID: 21465085)
21. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
[TBL] [Abstract][Full Text] [Related]
22. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil.
Rodrigues R; Scherer LC; Oliveira CM; Franco HM; Sperhacke RD; Ferreira JL; Castro SM; Stella IM; Brigido LF
Virus Res; 2006 Mar; 116(1-2):201-7. PubMed ID: 16332398
[TBL] [Abstract][Full Text] [Related]
23. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.
Monno L; Punzi G; Scarabaggio T; Saracino A; Brindicci G; Fiore JR; Iambrenghi OC; Di Stefano M; Pastore G; Angarano G
J Med Virol; 2003 May; 70(1):1-9. PubMed ID: 12629636
[TBL] [Abstract][Full Text] [Related]
24. Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.
Maes B; Schrooten Y; Snoeck J; Derdelinckx I; Van Ranst M; Vandamme AM; Van Laethem K
J Virol Methods; 2004 Jul; 119(1):45-9. PubMed ID: 15109820
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of HIV-1 non-B subtype infections in Northwest Poland.
Parczewski M; Leszczyszyn-Pynka M; Bander D; Urbańska A; Stańczak G; Boroń-Kaczmarska A
J Med Virol; 2010 Aug; 82(8):1306-13. PubMed ID: 20578066
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia).
Pérez-Alvarez L; Cuevas MT; Villahermosa ML; Pedreira JD; Manjón N; Herrero I; López-Calvo S; Delgado E; de Parga EV; Medrano L; Thomson MM; Taboada JA; Nájera R;
J Hum Virol; 2001; 4(1):35-8. PubMed ID: 11213931
[No Abstract] [Full Text] [Related]
27. Genetic variability of human immunodeficiency virus-1 in Bahia state, Northeast, Brazil: high diversity of HIV genotypes.
Monteiro JP; Alcantara LC; de Oliveira T; Oliveira AM; Melo MA; Brites C; Galvão-Castro B
J Med Virol; 2009 Mar; 81(3):391-9. PubMed ID: 19152417
[TBL] [Abstract][Full Text] [Related]
28. Emergence and diversity of different HIV-1 subtypes in South Africa, 2000-2001.
Jacobs GB; Loxton AG; Laten A; Robson B; van Rensburg EJ; Engelbrecht S
J Med Virol; 2009 Nov; 81(11):1852-9. PubMed ID: 19774685
[TBL] [Abstract][Full Text] [Related]
29. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
30. Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India.
Eshleman SH; Hudelson SE; Gupta A; Bollinger R; Divekar AD; Gangakhedkar RR; Kulkarni SS; Thakar MR; Paranjape RS; Tripathy S
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):93-7. PubMed ID: 15665648
[TBL] [Abstract][Full Text] [Related]
31. Performance of the ViroSeq HIV-1 genotyping system v2.0 on HIV-1 strains circulating in Senegal.
Thiam M; Diop-Ndiaye H; Kebe K; Vidal N; Diakhate-Lô R; Diouara AA; Leye N; Ndiaye O; Sow A; Ngom-Gueye NF; Mboup S; Toure-Kane C
J Virol Methods; 2013 Mar; 188(1-2):97-103. PubMed ID: 23266258
[TBL] [Abstract][Full Text] [Related]
32. Utility of the heteroduplex assay (HDA) as a simple and cost-effective tool for the identification of HIV type 1 dual infections in resource-limited settings.
Powell RL; Urbanski MM; Burda S; Nanfack A; Kinge T; Nyambi PN
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):100-5. PubMed ID: 18275354
[TBL] [Abstract][Full Text] [Related]
33. Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba.
Alemán Y; Vinken L; Kourí V; Pérez L; Álvarez A; Abrahantes Y; Fonseca C; Pérez J; Correa C; Soto Y; Schrooten Y; Vandamme AM; Van Laethem K
PLoS One; 2015; 10(2):e0117176. PubMed ID: 25671421
[TBL] [Abstract][Full Text] [Related]
34. High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity.
Aghokeng AF; Mpoudi-Ngole E; Chia JE; Edoul EM; Delaporte E; Peeters M
J Clin Microbiol; 2011 Apr; 49(4):1635-41. PubMed ID: 21270223
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.
Saravanan S; Vidya M; Balakrishnan P; Kumarasamy N; Solomon SS; Solomon S; Kantor R; Katzenstein D; Ramratnam B; Mayer KH
J Virol Methods; 2009 Aug; 159(2):211-6. PubMed ID: 19490976
[TBL] [Abstract][Full Text] [Related]
36. Confirmation of putative HIV-1 group P in Cameroon.
Vallari A; Holzmayer V; Harris B; Yamaguchi J; Ngansop C; Makamche F; Mbanya D; Kaptué L; Ndembi N; Gürtler L; Devare S; Brennan CA
J Virol; 2011 Feb; 85(3):1403-7. PubMed ID: 21084486
[TBL] [Abstract][Full Text] [Related]
37. Sequence analyses of the reverse transcriptase region of HIV type 1 isolates from Sydney, Australia.
Zheng NN; Hurren L; Neilan BA; Cooper DA; Delaney SF; McQueen PW
AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1731-2. PubMed ID: 8959251
[No Abstract] [Full Text] [Related]
38. Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon.
Janssens W; Nkengasong JN; Heyndrickx L; Fransen K; Ndumbe PM; Delaporte E; Peeters M; Perret JL; Ndoumou A; Atende C
AIDS; 1994 Jul; 8(7):1012-3. PubMed ID: 7946088
[No Abstract] [Full Text] [Related]
39. Short Communication: Characterization of a New HIV-1 Group N Isolate Originating from a Cameroonian Patient.
Tagnouokam Ngoupo PA; Sadeuh-Mba SA; De Oliveira F; Ngo-Malabo ET; Ngono L; Plantier JC; Kfutwah A; Njouom R
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):621-625. PubMed ID: 29575910
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 genetic variability in Cameroon.
Heyndrickx L; Janssens W; Ndumbe PM; Vereecken K; Coppens S; De Houwer K; Fransen K; Van der Auwera G; van der Groen G
AIDS; 2000 Aug; 14(12):1862-4. PubMed ID: 10985330
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
